2017 International Congress Archives - Page 8 of 155

Absence of depression in de novo Parkinson’s disease: a benign motor phenotype?

H.S. YOO, Y. Lee, J.J. Lee, S.J. Chung, P.H. Lee, Y.H. Sohn (Seoul, Republic of Korea)
Accuracy measures of imbalance bedside examination

y. xia, R. Thompson, D. Bhatti, A. Hellman, J. McKune, K. Suing, L. Schmaderer, K.-C. Siu, D. Torres-Russotto (omaha, NE, USA)
Acquisition, Validation and Preprocessing of Wrist-Worn Sensor Data in Patients with Parkinson’s Disease and Healthy Controls

D. Pichler, M. Lang, D. Kulić, F. Pfister, G. König, T. Um, A. Ahmadi, S. Endo, F. Achilles, K. Abedinpour, K. Bötzel, A. Ceballos-Baumann, S. Hirche, U. Fietzek (Munich, Germany)
Action Observation Training Effects on Brain Structural and Functional Changes in Parkinson’s Disease Patients

E. Sarasso, F. Agosta, M. Di Meo, M. Giacobbe, M.A. Volonté, G. Comi, A. Tettamanti, R. Gatti, M. Filippi (Milan, Italy)
Action tremor control with deep brain stimulation in patients with Parkinson’s disease: Specific target associations

K. Nozile-Firth, V. Viswanathan, K. Foote, M. Okun, A. Wagle Shukla (Gainesville, FL, USA)
Action Verb Generation as a marker of cognitive function in Parkinson disease

O. Yerokhin, K. Smith (Worcester, MA, USA)
Action Verbal Fluency is Related to the Functional Integrity of the Cognitive Cortico-Striatal Loop in Parkinson’s Disease

N. Auclair-Ouellet, A. Hanganu, E. Mazerolle, J. Sarna, M. Kibreab, J. Cheetham, I. Kathol, A. Haffenden, B. Pike, O. Monchi (Calgary, AB, Canada)
Active Arms: a randomized controlled trial of an interactive videogame for people with Parkinson’s disease

N. Allen, J. Song, S. Paul, S. Smith, J. O'Duffy, M. Schmidt, R. Love, C. Sherrington, C. Canning (Lidcombe, Australia)
Acute L-dopa Challenge Test In Early Parkinsonism With Respect To Presence Of Red Flag Signs &MRIAbnormalitis

M. ACHARYA, A. BISWAS, A. Chatterjee, S. DAS (KOLKATA, India)
Adding cues to a rat gambling task potentiates the increase in premature responding in response to chronic D2/3 agonist ropinirole without mitigating preference for risk

M. Tremblay, M. Barrus, P. Cocker, S. Kaur, C. Winstanley (Vancouver, BC, Canada)

« Previous Page
1
…
6
7
8
9
10
…
155
Next Page »